Number of Shares
4.39 Mil
Current Holdings Value*
$96.68 Mil
% of Portfolio
4.43%
Total Estimate Gain
$-38.67 Mil
% of Total Estimate Gain
-37.73%

Paradigm Biocapital Advisors LP's Edgewise Therapeutics Inc Holding Summary

As of 2025-03-31, Paradigm Biocapital Advisors LP held 4.39 Mil shares of Edgewise Therapeutics Inc(EWTX), totaling $96.68 Mil. This investment constitutes 4.43% of their stock portfolio, and Paradigm Biocapital Advisors LP now holds 4.18% of the outstanding Edgewise Therapeutics Inc(EWTX) stock.

The initial trade took place in 2024Q1. And since then Paradigm Biocapital Advisors LP has made 3 purchases of EWTX, at an average price of $22.21, for a total of 4.61 Mil shares. In addition, there have been 2 sales at an average price of $21.41 for 220,297.00 shares. Based on historical transaction data and EWTX's current price of $13.45, Paradigm Biocapital Advisors LP's estimated gain on his EWTX holdings is $-38.67 Mil, reflecting a -37.73% gain to date.

Paradigm Biocapital Advisors LP EWTX ($13.45) Holding Chart

Paradigm Biocapital Advisors LP EWTX ($13.45) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1